Enhancing medicine price transparency through price information mechanisms
Open Access
- 1 January 2014
- journal article
- Published by Springer Nature in Globalization and Health
- Vol. 10 (1) , 34
Abstract
Medicine price information mechanisms provide an essential tool to countries that seek a better understanding of product availability, market prices and price compositions of individual medicines. To be effective and contribute to cost savings, these mechanisms need to consider prices in their particular contexts when comparing between countries. This article discusses in what ways medicine price information mechanisms can contribute to increased price transparency and how this may affect access to medicines for developing countries.Keywords
This publication has 10 references indexed in Scilit:
- International Best Practices For Negotiating ‘Reimbursement Contracts’ With Price Rebates From Pharmaceutical CompaniesHealth Affairs, 2013
- Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databasesBulletin of the World Health Organization, 2009
- Price Transparency For Medical DevicesHealth Affairs, 2008
- Would Greater Transparency And Uniformity Of Health Care Prices Benefit Poor Patients?Health Affairs, 2007
- Drug and vaccine pricing and innovation: what is the story?Managerial and Decision Economics, 2007
- Countervailing Power and Price Transparency*The Scandinavian Journal of Economics, 2006
- Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets.2005
- Price Differentiation and Transparency in the Global Pharmaceutical MarketplacePharmacoEconomics, 2005
- Cross-national price differences for pharmaceuticals: how large, and why?Journal of Health Economics, 2000
- The Economics of InformationJournal of Political Economy, 1961